Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hydrolina Biotech is a Bulgarian biotechnology company specializing in the sustainable cultivation and processing of microalgae, with a primary focus on Spirulina. The company utilizes advanced photobioreactor technology to produce high-purity algal biomass and bioactive extracts for the nutraceutical, cosmetic, and food industries. By maintaining a controlled growth environment, Hydrolina Biotech ensures consistent quality and high concentrations of beneficial compounds such as phycocyanin. Their business model integrates innovative R&D with large-scale production to provide eco-friendly, plant-based solutions for global health and wellness markets. The company is recognized for its closed-loop approach to organic farming and biotechnology, positioning itself as a leader in the regional bio-economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hydrolina Biotech.